TP53 and posterior cortical atrophy: Indeed, in biopsy samples from PCa patients, mutations in TP53 were associated with visceral dissemination such as liver metastasis and early death, indicating a group of PCa patients that have a high risk of life-threatening disease who might benefit from more intensified treatment therapies [55].